Vermeltfoort J A
's Koonings Jaght, Arnhem.
Ned Tijdschr Geneeskd. 1991 Nov 16;135(46):2173-5.
At 's Koonings Jaght, a community for the mentally handicapped, 330 inhabitants who were seronegative for hepatitis B markers, were vaccinated with a DNA recombinant vaccine. Following primary vaccination, 87% of the inhabitants had an anti-HBs titer of greater than or equal to 10 IU/l while 68% had a titer of greater than or equal to 100 IU/l. It appears from the literature that a certain percentage of the non-responders and hyporesponders still develop sufficient protective antibodies after revaccination, directly following primary vaccination. Besides, it is known from the literature that a titer greater than or equal to 100 IU/l provides prolonged protection. For these reasons, 105 inhabitants whose anti-HBs titers were lower than 100 IU/l following primary vaccination, received one to three additional boosters, depending of the level of the titer. After this revaccination, 92% of the inhabitants had titers greater than or equal to 10 IU/l while 81% had titers greater than or equal to IU/l. From the results of the study it appears that following direct revaccination of non-responders and hyporesponders an additional percentage still reach the protective level of greater than 10 IU/l and that a not inconsiderable percentage achieve a titer providing prolonged protection. The conclusion therefore is that it is useful to revaccinate mentally handicapped persons with no or with low seroconversions following primary vaccination.
在库宁斯·贾赫特这个为智障人士设立的社区,330名乙肝标志物血清学阴性的居民接种了DNA重组疫苗。初次接种后,87%的居民抗-HBs滴度大于或等于10 IU/l,而68%的居民滴度大于或等于100 IU/l。从文献中可知,一定比例的无应答者和低应答者在初次接种后直接再次接种后仍会产生足够的保护性抗体。此外,从文献中还了解到,滴度大于或等于100 IU/l可提供长期保护。出于这些原因,105名初次接种后抗-HBs滴度低于100 IU/l的居民根据滴度水平额外接种了一至三次加强针。再次接种后,92%的居民滴度大于或等于10 IU/l,而81%的居民滴度大于或等于100 IU/l。从研究结果来看,无应答者和低应答者直接再次接种后,又有一定比例的人达到了大于10 IU/l的保护水平,而且有相当比例的人获得了能提供长期保护的滴度。因此结论是,对初次接种后无血清转化或血清转化水平低的智障人士进行再次接种是有用的。